LiverMultiScan shown to be a cost-effective alternative to liver biopsies for monitoring patients with autoimmune hepatitis

September 21, 2022

Perspectum Announces American Medical Association (AMA) Issues two Unique Category III CPT® Codes priced appropriately by the Centers for Medicare & Medicaid Services (CMS) for Noninvasive Biliary Anatomy Assessment With MRCP+

July 05, 2022

FDA Grants Clearance to Perspectum’s CoverScan – A New Platform-Based Tool to Assess Multiple Organs in One MRI Scan

May 22, 2022

LiverMultiScan® detected earlier stages of treatable disease in patients with autoimmune hepatitis to allow tailored treatment

March 21, 2022

LiverMultiScan® has achieved nationwide payer coverage for diagnosis and management of NAFLD and other established chronic liver diseases

March 14, 2022

First patient recruited for multi-year collaborative primary sclerosing cholangitis (PSC) pediatric study using Perspectum’s imaging technology to help predict disease progression and guide patient management

January 27, 2022

Perspectum partners with SimonMed to expand its impact on liver health and the clinical journey for patients with liver disease

January 13, 2022

New meta-analysis finds Perspectum’s non-invasive MRI biomarker cT1 is an effective alternative to biopsy for identifying patients at high risk of liver disease progression

January 12, 2022

Perspectum and HepQuant Announce Partnership to Bring a More Complete Picture of Liver Health

November 01, 2021